Access Statistics for Paul Grootendorst

Author contact details at EconPapers.

Working Paper File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
A review of instrumental variables estimation in the applied health sciences 1 4 16 637 2 7 43 1,587
An Empirical Analysis of Milk Addiction 0 0 0 0 0 2 8 244
Beneficiary Cost Sharing Under Canadian Provincial Prescription Drug Benefit Programs: History and Assessment 1 1 1 99 2 3 6 340
Do Drug Plans Matter? Effects of Drug Plan Eligibility on Drug Use Among the Elderly, Social Assistance Recipients and the General Population 1 1 2 108 1 1 4 579
Do Drug Plans Matter? Effects of Drug Plan Eligibility on Drug Use Among the Elderly, Social Assistance Recipients and the General Population 0 0 1 59 1 1 4 338
Does It Matter Whom and How You Ask? Inter and Intra-rater Agreement in the Ontario Health Survey 0 0 1 7 0 1 3 71
Does rising income inequality affect mortality rates in advanced economies? 0 0 3 37 2 5 17 77
Economic Instruments for Obesity Prevention: Results of a Scoping Review and Modified Delphi Survey 0 0 0 53 0 1 10 165
Effects of 'Authorized-Generics' on Canadian Drug Prices 0 1 6 218 6 105 203 988
Evidence of Construct Validity for Stoke and Arthritis in a Population Health Survey 0 0 0 29 0 0 3 251
Financial Incentives to Dispense Low-Cost Drugs: A Case Study of British Columbia Pharmacare 0 0 0 55 0 1 6 433
Health Utilities Index Mark 3: Evidence of Construct Validity for Stroke and Arthritis in a Population Health Survey 0 0 2 23 0 1 4 94
How should we support pharmaceutical innovation? 1 1 4 212 4 4 15 549
Intellectual Property Protection And Drug Plan Coverage: Evidence From Ontario 0 0 2 31 0 3 14 93
International Experience With Pharmaceutical Policy: Common Challenges and Lessons for Canada 0 0 2 81 0 2 7 279
National Catastrophic Drug Insurance Revisited: Who Would Benefit from Senator Kirby's Recommendations? 0 0 1 49 0 0 6 282
National Catastrophic Drug Insurance Revisited: Who Would Benefit from Senator Kirby's Recommendations? 0 0 0 57 0 0 2 512
New Approaches to Rewarding Pharmaceutical Innovation 0 1 1 91 0 1 3 152
On Becoming 65 in Ontario: Effects of Provincial Drug Plan Eligibility on Utilization of Prescription Medicines 0 0 1 19 0 0 3 81
Out-of-Pocket Prescription Drug Expenditures and Public Prescription Drug Programs 0 0 0 98 0 0 6 474
Out-of-Pocket Prescription Drug Expenditures and Public Prescription Drug Programs 0 0 3 173 0 0 9 466
Out-of-Pocket Prescription Drug Expenditures and Public Prescription Drug Programs 0 0 1 53 0 0 5 330
Patents, Public-Private Partnerships or Prizes – How should we support pharmaceutical innovation? 2 3 11 195 2 6 27 546
Results of an Investigation into the Integrity of the Ontario Health Survey 0 0 0 4 0 0 3 86
The Effects of Drug Subsidies on Out-of Pocket Prescription Drug Expenditures by Seniors: Regional Evidence from Canada 0 0 0 74 0 1 1 574
The Effects of Drug Subsidies on Out-of Pocket Prescription Drug Expenditures by Seniors: Regional Evidence from Canada 0 1 3 138 1 4 12 808
The Effects of Drug Subsidies on Out-of-Poket Prescription Drug Expenditures by seniors: regional Evidence from Canada 0 0 0 28 0 0 4 556
The Impact of Differential Cost Sharing of Non-Steroidal Anti-Inflammatory Agents on the Use and Costs of Analgesic Drugs 0 0 2 102 0 0 4 970
The Impact of Reference Pricing of Cardiovascular Drugs on Health Care Costs and Health Outcomes: Evidence from British Columbia -- Volume I: Summary 0 0 2 62 1 1 7 407
The Impact of Reference Pricing of Cardiovascular Drugs on Health Care Costs and Health Outcomes: Evidence from British Columbia -- Volume II: Technical Report 0 2 3 37 0 3 9 157
The Impact of Reference Pricing of Cardiovascular Drugs on Health Care Costs and Health Outcomes: Evidence from British Columbia--Volume I: Summary 0 0 0 127 1 1 4 715
The Impact of Reference Pricing of Cardiovascular Drugs on Health Care Costs and Health Outcomes: Evidence from British Columbia--Volume II: Technical Report 0 0 0 67 0 0 2 283
The life expectancy gains from pharmaceutical drugs: a critical appraisal of the literature 0 0 1 190 0 0 7 689
Variance in Pharmacare Coverage Across Canada 0 0 0 30 0 0 6 198
Total Working Papers 6 15 69 3,243 23 154 467 14,374


Journal Article File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
A re‐examination of the impact of reference pricing on anti‐hypertensive drug plan expenditures in British Columbia 0 0 0 35 0 0 3 138
An empirical analysis of milk addiction 0 0 2 107 0 3 20 526
Differences in Incremental Cost-Effectiveness Ratios for Common Versus Rare Conditions: A Case from Oncology 0 0 0 1 0 0 0 7
Distributional effects of `general population' prescription drug programs in Canada 0 0 0 48 0 0 2 389
Distributional effects of ‘general population’ prescription drug programs in Canada 0 0 0 0 0 1 1 1
Do downturns cause desperation? The effect of economic conditions on suicide rates in Canada 0 0 0 20 0 2 4 86
Does rising income inequality affect mortality rates in advanced economies? 0 0 1 4 0 3 11 48
Estimating the price elasticity of expenditure for prescription drugs in the presence of non‐linear price schedules: an illustration from Quebec, Canada 0 1 2 319 0 1 9 1,571
Health care policy evaluation using longitudinal insurance claims data: An application of the Panel Tobit estimator 0 1 2 4 1 2 3 230
National Catastrophic Drug Insurance Revisited: Who Would Benefit from Senator Kirby's Recommendations? 0 0 0 21 0 0 1 280
Newton's First Law as Applied to Pharmacies: Why Entry Order Matters for Generics 0 3 7 11 1 17 32 49
On the evaluation of drug benefits policy changes with longitudinal claims data: the policy maker's versus the clinician's perspective 0 0 0 4 0 0 3 23
The cost of drug development: A systematic review 0 0 6 58 1 2 18 191
The effects of coxib formulary restrictions on analgesic use and cost: Regional evidence from Canada 0 0 0 3 1 1 4 63
The effects of drug subsidies on out-of-pocket prescription drug expenditures by seniors: regional evidence from Canada 0 0 0 48 0 0 0 261
Total Journal Articles 0 5 20 683 4 32 111 3,863


Chapter File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Prescription Drug Insurance and Reimbursement 0 1 4 18 0 3 8 42
Prescription Drug Insurance and Reimbursement 0 0 0 11 0 1 3 38
Total Chapters 0 1 4 29 0 4 11 80


Statistics updated 2021-01-03